• Market entry and product research- We are avid and bespoke market researchers for clients interested in doing business in Africa or interested in knowing how their brands and new products are faring. We are known for launching excellent distributor searches for clients looking to build reliable partnerships in Subsaharan Africa
• Africa Corporate data sourcing and investigations- Afrique monitor helps to retrieve corporate files in Africa’s unique country administrations for clients, carries out various investigations on corporations and individuals within French and English-speaking Africa employing different methods like HUMINT, OSINT etc.
• Market data collection – We have over 1000 freelance data collectors who collect raw data in both popular and hard to reach markets in both quantitative and some qualitative research projects.
• Boutique business consulting and business development- Often, after market research, clients need assistance in kickstarting successful operations and require a number of essential services and reliable liaisons in their country of interest, our business finds joy in helping clients kickstart operations by connecting them with reliable stakeholders, helping them navigate complex regulatory roadblocks, providing assistance for their administrative procedures, looking for distributors etc. We provide boutique and sterling business consulting and business development services.

Our client base consists of mainly international clients and a few locally based ones.

We have carried out over 200 service scale projects and about 10 full scale projects where we have directly managed business development tasks until clients were fully operational in the country.

We have a repertoire of over 100 clients across our service offerings.

However, our most recent business development clients in the past 24 months include multinationals like GEA Group, Basel Holdings Cameroon Limited, Saprogrow Agrochemicals, Buckeye limited, Anteris global who we have worked with on two products IT Software and Pharmaceuticals in the past two years.